Effects of SC-26096(2-methyl-3-oxo-2azabicyclo(2.2.2.)octan-6-exo-yl 5-(4-biphenylyl)-3-methyl valerate), a new hypolipidemic agent, on mitochondrial respiration and oxidative phosphorylation.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000418:Albumins / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism; D001372:Aza Compounds / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D001952:Bridged-Ring Compounds / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D004140:Dinitrophenols / Q000494:pharmacology; D006885:Hydroxybutyrates / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009243:NAD / Q000037:antagonists & inhibitors; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D011506:Proteins / Q000378:metabolism; D051381:Rats; D013386:Succinates / Q000378:metabolism
D000418:Albumins; D001372:Aza Compounds; D001713:Biphenyl Compounds; D001952:Bridged-Ring Compounds; D004140:Dinitrophenols; D006885:Hydroxybutyrates; D000960:Hypolipidemic Agents; D011506:Proteins; D013386:Succinates; D009243:NAD; C006285:SC-26096; D000251:Adenosine Triphosphatases; D001205:Ascorbic Acid